Karuna Therapeutics Inc (KRTX)

NASDAQ
Currency in USD
329.83
0.00(0.00%)
Closed

KRTX Income Statement

Advanced Income Statement
Period Ending:
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa10.640.65
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-71.22%-93.85%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa--
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa10.640.65
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-71.22%-93.85%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa100%100%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa299.73494.84
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa-289.1-494.19
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-101.32%-70.94%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-2,717.83%-75,564.07%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa14.1861.18
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+2,724.3%+331.51%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa--
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa14.1861.18
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa--
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-274.92-433.01
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa--
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa--
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-274.92-433.01
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-91.18%-57.51%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa-2,584.54%-66,209.48%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa1.420.67
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa-276.34-433.68
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa--
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa-276.34-433.68
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-92.16%-56.94%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-2,597.88%-66,311.93%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa--
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa-276.34-433.68
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-8.74-11.73
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-77.03%-34.31%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-8.74-11.73
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-77.03%-34.31%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa31.6336.96
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa31.6336.96
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa--
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa--
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa-287.98-492.49
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-101.26%-71.01%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-2,707.38%-75,303.98%
EBIT
aa.aaaa.aaaa.aa